Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer

NDAQ:APHA - Post by User

Aphria Inc.

Bullboard Posts

Comment by ilvmyt5son Aug 02, 2020 2:22pm

670 Views

Post# 31355782

RE:RE:RE:I'm out of Aphria

Canaccord and Jefferies is working with Aphria to raise $135,000,000 for their expansion into the U.S.A. this November.

Distributions of the Common Shares through the ATM Program will be made pursuant to the terms of an equity distribution agreement dated July 29, 2020 among the Company, Jefferies LLC and Canaccord Genuity LLC, as U.S. agents and Canaccord Genuity Corp. and Jefferies Securities, Inc., as Canadian agents (collectively, the "Agents").

Canaccord Genuity analyst Matt Bottomley maintained a Buy rating on Aphria (NASDAQ:APHA) Inc on Thursday, setting a price target of C$10, which is approximately 24.87% above the present share price of $6.

According to TipRanks.com, Canaccord Genuity analyst Matt Bottomley is currently ranked with 4 stars on a 0-5 stars ranking scale, with an average return of 5.8% and a 50.64% success rate.